Publications by authors named "Chris Cameron"

Claim this Profile
E
Experimentally characterising the dynamical landscape of an active MEMS cantilever.
Seigan Hayashi, Chris Cameron, Stefanie Gutschmidt, Rua Murray, Bernd Krauskopf

Commun Eng· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 'Sandwich dressing technique' for management of the palate following soft tissue augmentation procedures: a case series.
Matthew K Morris, Aditya B Patel, Chris R Cameron, Anjali Y Bhagirath

J Surg Case Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eating disorders on medical wards: breaching clinical standards, patient rights and scopes of practice.
Cindy Towns, Vuk Sekicki, Kay Hodgetts, Phillipa Shirtcliffe, Chris Cameron

N Z Med J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023.
Ataru Igarashi, Shiro Tanaka, Raf De Moor, Nan Li, Mariko Hirozane, Chris Cameron

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023.
Ataru Igarashi, Shiro Tanaka, Raf De Moor, Nan Li, Mariko Hirozane, Chris Cameron

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices.
Shiro Tanaka, Ataru Igarashi, Raf De Moor, Nan Li, Mariko Hirozane, Chris Cameron

Value Health· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrode-Skin Impedance Model Parameter Estimation in the Frequency-Domain.
Chris J Cameron, Benjamin C Fortune, Christopher G Pretty, Michael P Hayes

Annu Int Conf IEEE Eng Med Biol Soc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant.
Ernest H Law, Chris Cameron

J Comp Eff Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Rena Buckstein, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Chris Cameron

Leuk Lymphoma· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry.
Rena Buckstein, Lisa Chodirker, Lee Mozessohn, Karen W L Yee, Michelle Geddes, Chris Cameron

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building infrastructure for outcomes-based agreements in Canada: can administrative health data be used to support an outcomes-based agreement in oncology?
Winson Y Cheung, Chris Cameron, Arif Mitha, Allison Wills

Support Care Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.
Imtiaz A Samjoo, Luisa Klotz, Gavin Giovannoni, Christopher Drudge, Anja Haltner, Chris Cameron

Mult Scler Relat Disord· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor Regarding "Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder".
Bruce A C Cree, Benjamin Greenberg, Chris Cameron, Brian G Weinshenker

Neurol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison.
Raymond S Douglas, Roger Dailey, Prem S Subramanian, Giuseppe Barbesino, Shoaib Ugradar, Chris Cameron

JAMA Ophthalmol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low cost circulatory pressure acquisition and fluid infusion rate measurement system for clinical research.
Rachel Smith, Amelia Rolfe, Chris Cameron, Geoffrey M Shaw, J Geoffrey Chase

HardwareX· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points.
Ernest Law, Roya Gavanji, Sarah Walsh, Anja Haltner, Rebecca McTavish, Chris Cameron

J Comp Eff Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter in reply.
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, Melody Zhao, Chris Cameron

J Comp Eff Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Paul Spin, Christopher Drudge, Chris Cameron

Curr Med Res Opin· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Tom Martin, Saad Z Usmani, Jordan M Schecter, Martin Vogel, Carolyn C Jackson, Chris Cameron

Curr Med Res Opin· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.
Stéphane de Botton, Joseph M Brandwein, Andrew H Wei, Arnaud Pigneux, Bruno Quesnel, Chris Cameron

Cancer Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studies.
Nadia Harbeck, Meaghan Bartlett, Dean Spurden, Becky Hooper, Lin Zhan, Chris Cameron

Future Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Elizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, Ernest H Law, Aaron Situ, Chris Cameron

Breast· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy classification of modern therapies in multiple sclerosis.
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, Melody Zhao, Chris Cameron

J Comp Eff Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer.
Hope S Rugo, Anja Haltner, Lin Zhan, Anh Tran, Eustratios Bananis, Chris Cameron

J Comp Eff Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis.
Imtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, Melody Zhao, Chris Cameron

J Comp Eff Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis